Home > Cashflow Statement > VENUS REMEDIES

VENUS REMEDIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

VENUS REMEDIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-1.02 Cr₹-1.08 Cr₹-0.57 Cr₹-9.48 Cr₹-162 Cr

What is the latest Cash Flow from Financing Activities ratio of VENUS REMEDIES ?

The latest Cash Flow from Financing Activities ratio of VENUS REMEDIES is ₹-1.02 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-1.02 Cr
Mar2024₹-1.08 Cr
Mar2023₹-0.57 Cr
Mar2022₹-9.48 Cr
Mar2021₹-162 Cr

How is Cash Flow from Financing Activities of VENUS REMEDIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-1.02 Cr
Negative
Mar2024 ₹-1.08 Cr
Negative
Mar2023 ₹-0.57 Cr
Negative
Mar2022 ₹-9.48 Cr
Negative
Mar2021 ₹-162 Cr -

Compare Cash Flow from Financing Activities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹900.7 Cr -9.6% -17.9% 121.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-9.6%

-17.9%

121.1%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses